Interaction between α-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses

被引:0
|
作者
Lu, XY
Barsh, GS
Akil, H
Watson, SJ
机构
[1] Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA
[2] Stanford Univ, Howard Hughes Med Inst, Dept Pediat, Stanford, CA 94305 USA
[3] Stanford Univ, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA
来源
JOURNAL OF NEUROSCIENCE | 2003年 / 23卷 / 21期
关键词
melanocortin-4; receptors; MTII; corticotropin-releasing hormone; alpha-helical-CRH9-41; paraventricular nucleus of the hypothalamus; food intake; hypothalamo-pituitary-adrenal axis;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Both central alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone (CRH) have been implicated in feeding and neuroendocrine mechanisms. The anatomical overlap and functional similarities between these two neurotransmitter systems led to the hypothesis that CRH might act as one of the mediators of the central actions of the melanocortin system. By double-labeling in situ hybridization, a subpopulation of CRH neurons in the paraventricular nucleus of the hypothalamus (PVN) were shown to contain the melanocortin-4 receptor (MC4R), concentrated in the ventromedial part of the parvicellular PVN ( up to 33%). Intracerebroventricular injection of melanocortin agonist MTII to conscious and freely moving rats induced a rapid induction of CRH gene transcription in the PVN. This effect was accompanied by a rise in plasma corticosterone levels in a dose- and time-dependent manner, with the maximum response observed 30 min after MTII injection. MTII (0.5 nmol)-induced increase in plasma corticosterone was attenuated by the selective MC4R antagonist HS014 (0.25-1.0 nmol) and nonselective CRH receptor antagonist alpha-helical-CRH9-41 (0.125-0.5 nmol) in a dose- dependent manner. Moreover, the anorectic effect of MTII was evaluated at 1, 2, and 24 hr after intracerebroventricular injection. Approximately half of the inhibitory effect of MTII (0.5 nmol) on food intake was reversed by pretreatment with alpha-helical-CRH9-41 at 0.25 and 0.5 nmol doses. Collectively, these results provide evidence that CRH acts as a downstream mediator of melanocortin signaling and contributes to the mechanisms by which the central melanocortin system controls feeding and neuroendocrine responses.
引用
收藏
页码:7863 / 7872
页数:10
相关论文
共 50 条
  • [21] ADDITIONAL EVIDENCE FOR DISSOCIATION OF MELANOCYTE-STIMULATING HORMONE AND CORTICOTROPIN RELEASE
    DUNN, JD
    KASTIN, AJ
    CARRILLO, AJ
    SCHALLY, AV
    JOURNAL OF ENDOCRINOLOGY, 1972, 55 (02) : 463 - 464
  • [22] HUMAN CORTICOTROPIN-RELEASING HORMONE TEST IN PATIENTS WITH HYPOTHALAMO-PITUITARY-ADRENOCORTICAL DISORDERS
    FUKATA, J
    SHIMIZU, N
    IMURA, H
    HIBI, I
    TANAKA, K
    TANAKA, T
    NAKAGAWA, S
    TAKEBE, K
    KIMURA, K
    YOSHINAGA, K
    TAKAKURA, K
    DEMURA, H
    IRIE, M
    MIYACHI, Y
    YANAIHARA, N
    YOSHIMI, T
    MIURA, K
    KUWAYAMA, A
    OTA, Z
    KATO, Y
    SAITO, S
    TAKAHARA, J
    HASHIMOTO, K
    NAWATA, H
    MATSUKURA, S
    ENDOCRINE JOURNAL, 1993, 40 (05) : 597 - 606
  • [23] Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress:: Differential regulation of adrenocorticotropin hormone and α-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone
    Rotllant, J
    Balm, PHM
    Ruane, NM
    Pérez-Sánchez, J
    Wendelaar-Bonga, SE
    Tort, L
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2000, 119 (02) : 152 - 163
  • [24] PITUITARY-ADRENAL RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN DIFFERENT DEGREES OF ADRENAL 21-HYDROXYLASE DEFICIENCY
    MOREIRA, AC
    ELIAS, LLK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (01): : 198 - 203
  • [25] CORTICOTROPIN-RELEASING HORMONE TESTING IN PITUITARY DISEASE
    LORIAUX, DL
    NIEMAN, L
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1991, 20 (02) : 363 - 369
  • [26] Corticotropin-releasing hormone as adrenal androgen secretagogue
    Ibáñez, L
    Potau, N
    Marcos, MV
    de Zegher, F
    PEDIATRIC RESEARCH, 1999, 46 (03) : 351 - 353
  • [27] Corticotropin-Releasing Hormone as Adrenal Androgen Secretagogue
    Lourdes Ibáñez
    Neus Potau
    Maria Victoria Marcos
    Francis de Zegher
    Pediatric Research, 1999, 46 : 351 - 353
  • [28] PITUITARY-ADRENAL RESPONSIVENESS TO CORTICOTROPIN-RELEASING HORMONE IN CHRONIC UREMIC PATIENTS
    SIAMOPOULOS, KC
    DARDAMANIS, M
    KYRIAKI, D
    PAPPAS, M
    SFEROPOULOS, G
    ALEVISOU, V
    PERITONEAL DIALYSIS INTERNATIONAL, 1990, 10 (02): : 153 - 156
  • [29] PLACENTAL CORTICOTROPIN-RELEASING HORMONE AND PITUITARY-ADRENAL-FUNCTION DURING PREGNANCY
    GOLAND, RS
    CONWELL, IM
    WARREN, WB
    WARDLAW, SL
    NEUROENDOCRINOLOGY, 1992, 56 (05) : 742 - 749
  • [30] MELANOCYTE-STIMULATING HORMONE AND PARKINSONISM - ROLE OF HYPOTHALAMIC RELEASING FACTORS
    SANDLER, M
    GOODWIN, BL
    LEASK, BGS
    RUTHVEN, CRJ
    LANCET, 1973, 1 (7803): : 611 - 612